Dermtech Plaplus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novavax, Inc Novavax, Inc. is a clinical-stage vaccine company that focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. With the onset of the global pandemic last year, the company has also ventured into making COVID-19 vaccines. Despite not having any product in the market yet and facing delays in production, it is still expected to be one of the leading vaccine candidates. The company’s vaccine has proven to be just as potent as other vaccine frontrunners. On Tuesday, President Joe Biden hinted that Novavax’s vaccine may be ne...

The Price And Volume Action In DermTech's Stock Today DermTech's (NASDAQ:DMTK) stock has been rising Tuesday, up 15.75% to a price of $49.28. The stock's volume is currently 2.83 million, which is roughly 208.88% of its recent 30-day volume average of 1.36 million. Why It's Moving Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: DermTech shares are trading higher after the company announced the launch DermTech PLAplusTM, its test for the enhanced early detection of melanoma. Further Analysis of Recent Price Action The moving average price of the...